Literature DB >> 25244981

Constitutive 53BP1/γH2AX foci are increased in cells of ALL patients dependent on BCR-ABL and TEL-AML1 preleukemic gene fusions.

A Somsedikova, E Markova, A Kolenova, J Puskacova, M Kubes, I Belyaev.   

Abstract

Childhood leukemia arises from hematopoietic stem cells by induction of mutations. Quite often chromosomal translocations arise prenatally as first key event in multistage process of leukemogenesis. These translocations result in so called preleukemic gene fusions (PGFs), such as BCR-ABL and TEL-AML1, which generate hybrid proteins with altered properties. Critical DNA damage resulting in translocations are DNA double-strand breaks (DSBs). BCR-ABL and TEL-AML1 were shown to be associated with increased constitutive DSBs in various model systems. We analyzed cells from peripheral blood and CD34-/CD34+ cells from bone marrow of pediatric acute lymphoblastic leukemia (ALL) patients harboring BCR-ABL or TEL-AML1. We used sensitive technique that is based on automated enumeration of DSB co-localizing proteins γH2AX and 53BP1, which form so called DNA repair foci. We found that level of constitutive γH2AX/53BP1 foci is significantly higher in cells of ALL pediatric patients than in healthy subjects. There was also significant increased level of constitutive γH2AX/53BP1 foci in cells from ALL patients harboring BCR-ABL or TEL-AML1 compared to patients without PGFs. The same increase was observed regardless cell type for both PGFs. Our data on increased DSB levels in the BCR-ABL/TEL-AML1 patient's cells support a model where BCR-ABL/TEL-AML1 induces DNA instability through facilitating mutagenesis and appearance of additional genetic alterations driving leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25244981     DOI: 10.4149/neo_2014_076

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  3 in total

1.  Low numbers of pre-leukemic fusion genes are frequently present in umbilical cord blood without affecting DNA damage response.

Authors:  Pavol Kosik; Milan Skorvaga; Matus Durdik; Lukas Jakl; Ekaterina Nikitina; Eva Markova; Katarina Kozics; Eva Horvathova; Igor Belyaev
Journal:  Oncotarget       Date:  2017-05-30

2.  Backtracked analysis of preleukemic fusion genes and DNA repair foci in umbilical cord blood of children with acute leukemia.

Authors:  Milan Škorvaga; Matúš Durdík; Pavol Košík; Eva Marková; Marek Holop; Miroslav Kubeš; Judita Puškáčová; Alexandra Kolenová; Igor Belyaev
Journal:  Oncotarget       Date:  2018-04-10

3.  Induction of AML Preleukemic Fusion Genes in HSPCs and DNA Damage Response in Preleukemic Fusion Gene Positive Samples.

Authors:  Pavol Kosik; Matus Durdik; Milan Skorvaga; Daniela Klimova; Dominika Kochanova; Zlatica Cerna; Miroslav Kubes; Marek Holop; Igor Belyaev
Journal:  Antioxidants (Basel)       Date:  2021-03-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.